Achillion Pharmaceuticals
ACHN
ACHN was delisted on the 27th of January, 2020.
0 hedge funds and large institutions have $0 invested in Achillion Pharmaceuticals in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 129 closing their positions.
100% less funds holding
Funds holding: 132 → 0 (-132)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $755M → $0 (-$755M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 129
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$79M |
| 2 |
BlackRock
New York
|
-$68.8M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$45.8M |
| 4 |
VI
Versor Investments
New York
|
-$45.3M |
| 5 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$45.3M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PAM
126
Panagora Asset Management
Boston,
Massachusetts
| – | -$4K | -628 | Closed |
|
|
NFG
127
Next Financial Group
Houston,
Texas
| – | -$4K | -600 | Closed |
|
128
Simplex Trading
Chicago,
Illinois
| – | -$3K | -600 | Closed |
|
|
FIB
129
First Interstate Bank
Billings,
Montana
| – | -$2K | -267 | Closed |
|
ACHN Hedge Fund Activity: Q1 2020 in Review
0 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Achillion Pharmaceuticals (ACHN) for Q1 2020, worth a combined $0 — down 100% from $755M a quarter earlier.
Sellers outnumbered buyers: 129 funds closed out of ACHN and 0 opened new positions — a net loss of 129 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Vanguard Group, exiting entirely with an estimated $79M sold.
- 0 institutional investors held Achillion Pharmaceuticals (ACHN) as of Q1 2020, down from 132 in Q4 2019.
- Funds reported $0 of Achillion Pharmaceuticals stock for Q1 2020, down 100% quarter-over-quarter.
- 0 funds opened new Achillion Pharmaceuticals positions in Q1 2020 and 129 closed out, a net change of -129 holders.
- The largest Achillion Pharmaceuticals seller in Q1 2020 was Vanguard Group, an estimated $79M sold.
Based on aggregated 13F filings for Q1 2020.